BD Pyxis™
2 days ago · BD Pyxis™ medication management software and medication dispensing machines enable a consistent approach to medication management across your organization to help keep teams …
Inline & Handheld Analytical Tools for Water Treatment | Pyxis Lab®
At Pyxis Lab® we pride ourselves on offering high quality inline sensors, handheld analytical devices, pre-mounted panel packages & fluorescent tracing chemicals that have impressed some of the best …
Pyxis - Wikipedia
Abbreviated from Pyxis Nautica, its name is Latin for a mariner's compass (contrasting with Circinus, which represents a draftsman's compasses). Pyxis was introduced by Nicolas-Louis de Lacaille in …
Pyxis Oncology Announces Positive Preliminary Phase 1 Data for ...
Dec 18, 2025 · Pyxis Oncology is focused on advancing MICVO, with the goal of improving outcomes for patients living with R/M HNSCC and contributing to meaningful progress in cancer treatment.
Pyxis Oncology | Homepage
Nov 3, 2025 · Pyxis Oncology has assembled a differentiated portfolio of clinical assets, including antibody-drug conjugates (ADCs) and monoclonal antibody (mAb) immunotherapies, with the …
Pyxis to present updated data from phase 1 monotherapy study in
In mid-2026, Pyxis Oncology (PYXS) plans to present updated data from the ongoing Phase 1 monotherapy study in 2L+ R/M HNSCC, which is expected to include additional patients and initial ...
Blackmagic PYXIS 12K Review: Full-Frame 12K RAW in the Real World
Dec 19, 2025 · A one-month real-world review of the Blackmagic PYXIS 12K. Image quality, RAW workflow, pros, cons, and who this full-frame camera is really for.
Pyxis Oncology Stock (PYXS) Opinions on Phase 1 Cancer Drug Data
Dec 18, 2025 · Drug Data Release: Recent buzz on social media has centered around Pyxis Oncology's latest announcement of preliminary Phase 1 data for its cancer drug, Micvotabart Pelidotin, targeting …
Analysts Sound Alarm On Pyxis Oncology's Tiny Trial
Dec 19, 2025 · Pyxis Oncology released preliminary data from Phase 1 studies of MICVO for recurrent/metastatic head and neck squamous cell carcinoma.
Pyxis Oncology Announces Positive Preliminary Phase 1 Data
Dec 18, 2025 · Pyxis Oncology will host a live conference call and webcast at 8:30 a.m. ET today to review the preliminary Phase 1 clinical trial data. Participants may register for the conference call here.